Roland B. Walter

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 42 papers. Top paper: “Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia”.

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood(2020)10.1182/blood.2020007732

N/A

4.0DataRank · unranked

322 citations

Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1786553

N/A

0DataRank · unranked

15 citations

Olivia M. Bates, Sae Rin Jean, George S. Laszlo, Eliotte E. Garling, Mary E. Beddoe +3 more

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Cancers(2020)10.3390/cancers12092339

N/A

0DataRank · unranked

41 citations

Brenda M. Sandmaier, Megan Othus, Raffaele Palmieri, Noa Granot, Evandro D. Bezerra +10 more

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Blood Advances(2020)10.1182/bloodadvances.2019000707

N/A

0DataRank · unranked

28 citations

Kelda M. Gardner, Kathleen Shannon Dorcy, Andrea Perdue, Heather Smith, Alicyn M. Davis +12 more

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

Haematologica(2020)10.3324/haematol.2020.254938

N/A

0DataRank · unranked

5 citations

Megan Othus, Sarah Mirahsani, Kelda M. Gardner, Carole Shaw, Anna B. Halpern +6 more

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Blood(2021)10.1182/blood.2021013626

N/A

0DataRank · unranked

738 citations

Sylvie Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai +40 more

Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations

Leukemia(2021)10.1038/s41375-021-01230-4

N/A

0DataRank · unranked

80 citations

Yishai Ofran, Agnieszka Wierzbowska, Farhad Ravandi, Christopher S. Hourigan, Lok Lam Ngai +5 more

Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both?

Leukemia(2021)10.1038/s41375-021-01419-7

N/A

0DataRank · unranked

10 citations

Neil E. Kay, Min Shi, Gert J. Ossenkoppele, Roland B. Walter, Robert Peter Gale +1 more

Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1881512

N/A

0DataRank · unranked

2 citations

Megan Othus, Guillermo Garcia‐Manero, Frederick R. Appelbaum, Harry P. Erba, Roland B. Walter +1 more

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

Haematologica(2022)10.3324/haematol.2022.281585

N/A

0DataRank · unranked

27 citations

Jacob A. Wilson, Min Fang, Brenda M. Sandmaier, Eduardo Rodríguez‐Arbolí, Brent L. Wood +4 more

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Haematologica(2022)10.3324/haematol.2022.281631

N/A

0DataRank · unranked

21 citations

Megan Othus, Corentin Orvain, Lucas C. Zarling, Brenda M. Sandmaier, Filippo Milano +7 more

Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.09.023

N/A

0DataRank · unranked

15 citations

Mariia Byelykh, Megan Othus, Brenda M. Sandmaier, Gary Schoch, Chris Davis +3 more

A randomized phase II/III study of ‘novel therapeutics’ versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2148212

N/A

0DataRank · unranked

14 citations

Laura C. Michaelis, Megan Othus, Annette E. Hay, Roland B. Walter, Meagan A. Jacoby +15 more

Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making

Oncology and Therapy(2022)10.1007/s40487-022-00200-9

N/A

0DataRank · unranked

12 citations

Nigel H. Russell, Loriana Hernandez-Aldama, Charlotte Panter, Timothy Bell, Verna Welch +14 more

Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission

Bone Marrow Transplantation(2022)10.1038/s41409-022-01909-x

N/A

0DataRank · unranked

12 citations

Brenda M. Sandmaier, Megan Othus, Corentin Orvain, Eduardo Rodríguez‐Arbolí, Masumi Ueda +5 more

Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation(2022)10.1038/s41409-022-01794-4

N/A

0DataRank · unranked

11 citations

Corentin Orvain, Megan Othus, Roland B. Walter, Eduardo Rodríguez‐Arbolí

Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2131416

N/A

0DataRank · unranked

0 citations

Ian Thomas, Xu Wang, Cono Ariti, Priyanka Mehta, Mia Sydenham +11 more

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel

American Journal of Hematology(2023)10.1002/ajh.27087

N/A

0DataRank · unranked

24 citations

Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman +12 more

Efficient long-term multilineage engraftment of CD33-edited hematopoietic stem/progenitor cells in nonhuman primates

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.101121

N/A

0DataRank · unranked

10 citations

Stefan Radtke, Emily Fields, Olivier Humbert, Mallory J Llewellyn, George S. Laszlo +5 more

[ 211 At]astatine-based anti-CD22 radioimmunotherapy for B-cell malignancies

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2210710

N/A

0DataRank · unranked

4 citations

Brenda M. Sandmaier, Allie R. Kehret, Johnnie J. Orozco, Donald K. Hamlin, Shannon L. Dexter +6 more

A phase I trial of dose-adjusted EPOCH plus inotuzumab ozogamicin (InO) in adults with relapsed/refractory (R/R) B lymphoblastic leukemia/lymphoma (B-ALL).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7007

N/A

0DataRank · unranked

1 citations

Kim Quach, Ted Gooley, Christen H. Martino, Sindhu Cherian, Mary‐Elizabeth M. Percival +8 more

Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML

Blood Advances(2024)10.1182/bloodadvances.2024013214

N/A

0DataRank · unranked

19 citations

Megan Othus, Eduardo Rodríguez‐Arbolí, Corentin Orvain, Filippo Milano, Brenda M. Sandmaier +5 more

Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia

Leukemia(2024)10.1038/s41375-024-02172-3

N/A

0DataRank · unranked

12 citations

Megan Othus, Corentin Orvain, Eduardo Rodríguez‐Arbolí, Filippo Milano, Brenda M. Sandmaier +6 more

Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)

Leukemia(2024)10.1038/s41375-024-02378-5

N/A

0DataRank · unranked

12 citations

Megan Othus, Sylvie Freeman, Francesco Buccisano, Lok Lam Ngai, Ian Thomas +11 more

Time independent factors that predict relapse in adults with acute myeloid leukemia

Blood Cancer Journal(2024)10.1038/s41408-023-00954-z

N/A

0DataRank · unranked

8 citations

Megan Othus, Carole Shaw, Kathryn Russell, Anna B. Halpern, Jacob Appelbaum +5 more

Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200854

N/A

0DataRank · unranked

9 citations

Sheryl Y.T. Lim, George S. Laszlo, Erik L. Kimble, Tinh-Doan Phi, Margaret C. Lunn-Halbert +6 more

Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML

American Journal of Hematology(2024)10.1002/ajh.27259

N/A

0DataRank · unranked

8 citations

Naveed Ali, Megan Othus, Eduardo Rodríguez‐Arbolí, Filippo Milano, Calvin M. Le +5 more

Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.019

N/A

0DataRank · unranked

7 citations

Megan Othus, Corentin Orvain, Naveed Ali, Filippo Milano, Chris Davis +6 more

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

Leukemia(2024)10.1038/s41375-024-02143-8

N/A

0DataRank · unranked

6 citations

Andrew H. Wei, Sumithra J. Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse‐Chieh Teh +24 more

Relationship between morphologic remission with or without hematologic recovery and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02407-y

N/A

0DataRank · unranked

2 citations

Domitilla Baccon, Naveed Ali, Eduardo Rodríguez‐Arbolí, Corentin Orvain, Filippo Milano +5 more

Relationship Between Age, Conditioning Intensity, and Outcome After Allografting in Adults Age ≥60 Years with AML

Research Square(2024)10.21203/rs.3.rs-5220097/v1

N/A

0DataRank · unranked

0 citations

Brenda M. Sandmaier, Megan Othus, Naveed Ali, Eduardo Rodríguez‐Arbolí, Corentin Orvain +5 more

Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy

Nature Communications(2025)10.1038/s41467-025-59713-2

N/A

0DataRank · unranked

10 citations

Olivier Humbert, Jeffrey T. Ehmsen, Emily Fields, Sajeev Kohli, Stefan Radtke +14 more

Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samples

npj Biofilms and Microbiomes(2025)10.1038/s41522-025-00725-7

N/A

0DataRank · unranked

5 citations

Hakan Gem, Kevin K. Chung, Jeffrey S. McLean, Kristopher A. Kerns, Meredith A.J. Hullar +10 more

Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AML

Bone Marrow Transplantation(2025)10.1038/s41409-025-02516-2

N/A

0DataRank · unranked

5 citations

Brenda M. Sandmaier, Megan Othus, Naveed Ali, Eduardo Rodríguez‐Arbolí, Corentin Orvain +5 more

Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques

Blood Advances(2025)10.1182/bloodadvances.2024015016

N/A

0DataRank · unranked

4 citations

Stefan Radtke, Greta Kanestrom, Emily Fields, Olivier Humbert, Salvatore Fiorenza +11 more

Biobanking and consent to future biospecimen use among adults enrolled in SWOG trials from 2000 to 2024

Blood Cancer Journal(2025)10.1038/s41408-025-01294-w

N/A

0DataRank · unranked

2 citations

Alexis Berridge-Green, Megan Othus, Jerald P. Radich, Anjali S. Advani, Harry P. Erba +2 more

Modulators of relapse risk in adults allografted for acute myeloid leukemia in measurable residual disease-positive remission

Bone Marrow Transplantation(2025)10.1038/s41409-025-02533-1

N/A

0DataRank · unranked

1 citations

Megan Othus, Brenda M. Sandmaier, Chris Davis, Ryan Basom, Roland B. Walter +1 more

CD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia

Cancers(2025)10.3390/cancers17142323

N/A

0DataRank · unranked

1 citations

Megan Othus, Anne-Chloe Olix, Kate A. Markey, Derek L. Stirewalt, Laura Connelly‐Smith +4 more

Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies

Haematologica(2025)10.3324/haematol.2024.286593

N/A

0DataRank · unranked

0 citations

Frances M. Cole, George S. Laszlo, Margaret C. Lunn-Halbert, Jenny Huo, Junyang Li +3 more

Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

JAMA Oncology(2020)10.1001/jamaoncol.2020.4600

N/A

0DataRank · unranked

373 citations

Shouhao Zhou, Chenqi Fu, Donald A. Berry, Roland B. Walter, Sylvie Freeman +8 more

National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.031

N/A

0DataRank · unranked

0 citations

Helene Starks, Lindsey Bandini, T. Harrington, Mary‐Elizabeth M. Percival, Roland B. Walter +6 more